S
Sundari Mase
Researcher at World Health Organization
Publications - 36
Citations - 1773
Sundari Mase is an academic researcher from World Health Organization. The author has contributed to research in topics: Tuberculosis & Regimen. The author has an hindex of 16, co-authored 36 publications receiving 1321 citations. Previous affiliations of Sundari Mase include Centers for Disease Control and Prevention.
Papers
More filters
Journal ArticleDOI
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
Nafees Ahmad,Shama D. Ahuja,Onno W. Akkerman,Jan-Willem C. Alffenaar,Laura F Anderson,Parvaneh Baghaei,Didi Bang,Pennan M. Barry,Mayara Lisboa Bastos,Digamber Behera,Andrea Benedetti,Gregory P. Bisson,Martin J. Boeree,Maryline Bonnet,Sarah K. Brode,James C.M. Brust,Ying Cai,Eric Caumes,J. Peter Cegielski,Rosella Centis,Pei-Chun Chan,Edward D. Chan,Kwok-Chiu Chang,Macarthur Charles,Andra Cirule,Margareth Pretti Dalcolmo,Lia D'Ambrosio,Gerard de Vries,Keertan Dheda,Aliasgar Esmail,Jennifer Flood,Gregory J. Fox,Mathilde Fréchet-Jachym,Geisa Fregona,Regina Gayoso,Medea Gegia,Maria Tarcela Gler,Sue Gu,Lorenzo Guglielmetti,Timothy H. Holtz,Jennifer Hughes,Petros Isaakidis,Leah G. Jarlsberg,Russell R. Kempker,Salmaan Keshavjee,Faiz Ahmad Khan,Maia Kipiani,Serena P. Koenig,Won-Jung Koh,Afranio Lineu Kritski,Liga Kuksa,Charlotte Kvasnovsky,Nakwon Kwak,Zhiyi Lan,Christoph Lange,Rafael Laniado-Laborín,Myungsun Lee,Vaira Leimane,Chi-Chiu Leung,Eric Chung Ching Leung,Pei Zhi Li,Phil Lowenthal,Ethel Leonor Noia Maciel,Suzanne M. Marks,Sundari Mase,Lawrence Mbuagbaw,Giovanni Battista Migliori,Vladimir Milanov,Ann C. Miller,Carole D. Mitnick,Chawangwa Modongo,Erika Mohr,Ignacio Monedero,Payam Nahid,Norbert Ndjeka,Max R. O'Donnell,Nesri Padayatchi,Domingo Palmero,Jean W. Pape,Laura Jean Podewils,Ian R Reynolds,Vija Riekstina,Jérôme Robert,Maria I. Rodriguez,Barbara Seaworth,Kwonjune J. Seung,Kathryn Schnippel,Tae Sun Shim,Rupak Singla,Sarah Smith,Giovanni Sotgiu,Ganzaya Sukhbaatar,Payam Tabarsi,Simon Tiberi,Anete Trajman,Lisa Trieu,Zarir F Udwadia,Tjip S. van der Werf,Nicolas Veziris,Piret Viiklepp,Stalz Charles Vilbrun,Kathleen F. Walsh,Janice Westenhouse,Wing Wai Yew,Jae-Joon Yim,Nicola M. Zetola,Matteo Zignol,Dick Menzies +107 more
TL;DR: Treatment outcomes were significantly better with use of linezolid, later generation fluoroquinolones, bedaquiline, clofazimine, and carbapenems for treatment of multidrug-resistant tuberculosis, and the need for trials to ascertain the optimal combination and duration of these drugs is emphasised.
Journal ArticleDOI
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
Payam Nahid,Sundari Mase,Giovanni Battista Migliori,Giovanni Sotgiu,Graham H. Bothamley,Jan Brozek,Adithya Cattamanchi,J. Peter Cegielski,Lisa Chen,Charles L. Daley,Tracy Dalton,Raquel Duarte,Federica Fregonese,C. Robert Horsburgh,Faiz Ahmad Khan,Fayez Kheir,Zhiyi Lan,Alfred Lardizabal,Michael Lauzardo,Joan M. Mangan,Suzanne M. Marks,Lindsay McKenna,Dick Menzies,Carole D. Mitnick,Diana M. Nilsen,Farah Parvez,Charles A. Peloquin,Ann Raftery,H. Simon Schaaf,Neha Shah,Jeffrey R. Starke,John W. Wilson,Jonathan M. Wortham,Terence Chorba,Barbara Seaworth +34 more
TL;DR: New recommendations are made for the choice and number of drugs in a regimen, the duration of intensive and continuation phases, and the role of injectable drugs for MDR-TB.
Journal ArticleDOI
Linezolid in the treatment of multidrug-resistant tuberculosis.
Gisela F. Schecter,Colleen Scott,Colleen Scott,Lisa True,A. Raftery,Jennifer Flood,Sundari Mase +6 more
TL;DR: Linezolid was well tolerated, had low rates of discontinuation, and may have efficacy in the treatment of MDR-TB.
Journal ArticleDOI
Treatment practices, outcomes, and costs of multidrug-resistant and extensively drug-resistant tuberculosis, United States, 2005-2007.
Suzanne M. Marks,Jennifer Flood,Barbara Seaworth,Yael Hirsch-Moverman,Lori R. Armstrong,Sundari Mase,Katya Salcedo,Peter Oh,Edward A. Graviss,Paul W. Colson,Lisa Armitige,Manuel Revuelta,Kathryn Sheeran +12 more
TL;DR: Drug resistance was extensive and care was complex; nevertheless, high rates of treatment completion were achieved albeit at considerable cost.
Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis
TL;DR: This report provides provisional CDC guidelines for FDA-approved and unapproved, or off-label, uses of bedaquiline in certain populations, such as children, pregnant women, or persons with extrapulmonary MDR TB who were not included in the clinical trials for the drug.